Could This Be the First Disease-Modifying Drug in Bronchiectasis?

By News Health
2 months Ago

(MedPage Today) — CHICAGO — Brensocatib (Brinsupri) appeared to have a disease-modifying effect on structural lung changes in non-cystic fibrosis bronchiectasis at its higher dose, a CT substudy of the ASPEN trial showed.
At the 25-mg dose…

Source link : https://www.medpagetoday.com/meetingcoverage/chest/118083

Author :

Publish date : 2025-10-22 17:20:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

What Did Trump's MRI Assess?

For People With Seizures, It May Be Better to Be Old

Neflamapimod Shows Promise in Dementia With Lewy Bodies

Tai Chi for Insomnia; WHO Guidance on GLP-1 Drugs

The Other Screen Time Risk We Rarely Hear About

Nerve Stimulation for Epilepsy: Intracranial Versus Extracranial Approaches Compared